pubmed-article:10779636 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10779636 | lifeskim:mentions | umls-concept:C0439849 | lld:lifeskim |
pubmed-article:10779636 | lifeskim:mentions | umls-concept:C0242643 | lld:lifeskim |
pubmed-article:10779636 | lifeskim:mentions | umls-concept:C0242640 | lld:lifeskim |
pubmed-article:10779636 | lifeskim:mentions | umls-concept:C0162680 | lld:lifeskim |
pubmed-article:10779636 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
pubmed-article:10779636 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
pubmed-article:10779636 | lifeskim:mentions | umls-concept:C0445223 | lld:lifeskim |
pubmed-article:10779636 | lifeskim:mentions | umls-concept:C1552599 | lld:lifeskim |
pubmed-article:10779636 | lifeskim:mentions | umls-concept:C1704787 | lld:lifeskim |
pubmed-article:10779636 | lifeskim:mentions | umls-concept:C0127400 | lld:lifeskim |
pubmed-article:10779636 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
pubmed-article:10779636 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
pubmed-article:10779636 | pubmed:issue | 1-2 | lld:pubmed |
pubmed-article:10779636 | pubmed:dateCreated | 2000-6-13 | lld:pubmed |
pubmed-article:10779636 | pubmed:abstractText | We prospectively studied a total of 24 patients with breast cancer to evaluate the relationship between the degree of accumulation of technetium-99m sestamibi (Tc-99m MIBI) and p-glycoprotein (Pgp) expression in tumor tissues. All 24 patients underwent Tc-99m MIBI scintimammography before surgery or biopsy. Immunohistochemical studies were performed on multiple non-consecutive sections of the same tumor using a Pgp specific monoclonal antibody, JSB-1. Planar images were started 10 min after injection of Tc-99m MIBI. Tumor to background (T/B) ratios calculated from the planar images were correlated with Pgp expression as determined by immunohistochemical studies. The T/B ratios were significantly lower for tumors in eight patients with positive Pgp expression (Group 1) than in 16 patients with negative expression (Group 2) (1.40+/-0.11 and 2.76+/-0.60, P<0. 05). Our data confirmed that Tc-99m MIBI scintimammography is useful for determination of the presence of multidrug resistance due to Pgp expression in patients with breast cancer. | lld:pubmed |
pubmed-article:10779636 | pubmed:language | eng | lld:pubmed |
pubmed-article:10779636 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10779636 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:10779636 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10779636 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10779636 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10779636 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10779636 | pubmed:month | May | lld:pubmed |
pubmed-article:10779636 | pubmed:issn | 0304-3835 | lld:pubmed |
pubmed-article:10779636 | pubmed:author | pubmed-author:TsaiS CSC | lld:pubmed |
pubmed-article:10779636 | pubmed:author | pubmed-author:LeeJ KJK | lld:pubmed |
pubmed-article:10779636 | pubmed:author | pubmed-author:KaoC HCH | lld:pubmed |
pubmed-article:10779636 | pubmed:author | pubmed-author:SunS SSS | lld:pubmed |
pubmed-article:10779636 | pubmed:author | pubmed-author:YimYY | lld:pubmed |
pubmed-article:10779636 | pubmed:author | pubmed-author:HsiehJ FJF | lld:pubmed |
pubmed-article:10779636 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10779636 | pubmed:day | 29 | lld:pubmed |
pubmed-article:10779636 | pubmed:volume | 153 | lld:pubmed |
pubmed-article:10779636 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10779636 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10779636 | pubmed:pagination | 95-100 | lld:pubmed |
pubmed-article:10779636 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:10779636 | pubmed:meshHeading | pubmed-meshheading:10779636... | lld:pubmed |
pubmed-article:10779636 | pubmed:meshHeading | pubmed-meshheading:10779636... | lld:pubmed |
pubmed-article:10779636 | pubmed:meshHeading | pubmed-meshheading:10779636... | lld:pubmed |
pubmed-article:10779636 | pubmed:meshHeading | pubmed-meshheading:10779636... | lld:pubmed |
pubmed-article:10779636 | pubmed:meshHeading | pubmed-meshheading:10779636... | lld:pubmed |
pubmed-article:10779636 | pubmed:meshHeading | pubmed-meshheading:10779636... | lld:pubmed |
pubmed-article:10779636 | pubmed:meshHeading | pubmed-meshheading:10779636... | lld:pubmed |
pubmed-article:10779636 | pubmed:meshHeading | pubmed-meshheading:10779636... | lld:pubmed |
pubmed-article:10779636 | pubmed:meshHeading | pubmed-meshheading:10779636... | lld:pubmed |
pubmed-article:10779636 | pubmed:meshHeading | pubmed-meshheading:10779636... | lld:pubmed |
pubmed-article:10779636 | pubmed:meshHeading | pubmed-meshheading:10779636... | lld:pubmed |
pubmed-article:10779636 | pubmed:meshHeading | pubmed-meshheading:10779636... | lld:pubmed |
pubmed-article:10779636 | pubmed:year | 2000 | lld:pubmed |
pubmed-article:10779636 | pubmed:articleTitle | Expression of mediated P-glycoprotein multidrug resistance related to Tc-99m MIBI scintimammography results. | lld:pubmed |
pubmed-article:10779636 | pubmed:affiliation | Department of Nuclear Medicine, China Medical College Hospital, Taichung, Taiwan. | lld:pubmed |
pubmed-article:10779636 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:10779636 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:10779636 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10779636 | lld:pubmed |